Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Reclustering and indirect immunofluorescence assays on MT-4 cells [carrying both CD4 and complement receptor type 2 (CR2)] were used to measure neutralizing and enhancing antibodies in sera obtained from HIV-1-infected individuals. Heat-inactivated sera were tested before and after mixing 1:1 with fresh seronegative human serum. Using heated samples, neutralizing antibodies were found in 20 out of 20 and 11 out of 19 serum samples of asymptomatic and symptomatic [AIDS, AIDS-related complex (ARC)] HIV-seropositive patients, respectively. In complement-restored samples, neutralizing activity was found in eight sera of asymptomatic patients and in none of the sera of AIDS and ARC patients; enhancing activity could be detected in four and 12 sera, respectively. A significant positive correlation was observed between the titres of neutralizing antibodies measured in the complement-restored samples and the absolute number of CD4+ lymphocytes. These findings indicate that the appearance of complement-dependent enhancing antibodies coincident with the loss of neutralizing antibodies may indicate a poor prognosis in HIV infection.

Original languageEnglish
Pages (from-to)263-268
Number of pages6
JournalAIDS
Volume5
Issue number3
Publication statusPublished - Mar 1991

Fingerprint

Blocking Antibodies
HIV Infections
Neutralizing Antibodies
Serum
AIDS-Related Complex
Acquired Immunodeficiency Syndrome
Complement 3d Receptors
CD4 Antigens
Lymphocyte Count
Indirect Fluorescent Antibody Technique
HIV-1
Hot Temperature
HIV

Keywords

  • AIDS
  • ARC
  • Complement receptors
  • MT-4
  • Neutralizing and enhancing HIV antibodies
  • Prognosis

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

@article{4fd8360cf2664e45b3e643914601c17c,
title = "Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection",
abstract = "Reclustering and indirect immunofluorescence assays on MT-4 cells [carrying both CD4 and complement receptor type 2 (CR2)] were used to measure neutralizing and enhancing antibodies in sera obtained from HIV-1-infected individuals. Heat-inactivated sera were tested before and after mixing 1:1 with fresh seronegative human serum. Using heated samples, neutralizing antibodies were found in 20 out of 20 and 11 out of 19 serum samples of asymptomatic and symptomatic [AIDS, AIDS-related complex (ARC)] HIV-seropositive patients, respectively. In complement-restored samples, neutralizing activity was found in eight sera of asymptomatic patients and in none of the sera of AIDS and ARC patients; enhancing activity could be detected in four and 12 sera, respectively. A significant positive correlation was observed between the titres of neutralizing antibodies measured in the complement-restored samples and the absolute number of CD4+ lymphocytes. These findings indicate that the appearance of complement-dependent enhancing antibodies coincident with the loss of neutralizing antibodies may indicate a poor prognosis in HIV infection.",
keywords = "AIDS, ARC, Complement receptors, MT-4, Neutralizing and enhancing HIV antibodies, Prognosis",
author = "F. T{\'o}th and B{\'e}la Szab{\'o} and E. {\'U}jhelyi and K. P{\'a}l{\'o}czi and A. Horv{\'a}th and G. F{\"u}st and Jol{\'a}n Kiss and D. B{\'a}nhegyi and S. Holl{\'a}n",
year = "1991",
month = "3",
language = "English",
volume = "5",
pages = "263--268",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection

AU - Tóth, F.

AU - Szabó, Béla

AU - Újhelyi, E.

AU - Pálóczi, K.

AU - Horváth, A.

AU - Füst, G.

AU - Kiss, Jolán

AU - Bánhegyi, D.

AU - Hollán, S.

PY - 1991/3

Y1 - 1991/3

N2 - Reclustering and indirect immunofluorescence assays on MT-4 cells [carrying both CD4 and complement receptor type 2 (CR2)] were used to measure neutralizing and enhancing antibodies in sera obtained from HIV-1-infected individuals. Heat-inactivated sera were tested before and after mixing 1:1 with fresh seronegative human serum. Using heated samples, neutralizing antibodies were found in 20 out of 20 and 11 out of 19 serum samples of asymptomatic and symptomatic [AIDS, AIDS-related complex (ARC)] HIV-seropositive patients, respectively. In complement-restored samples, neutralizing activity was found in eight sera of asymptomatic patients and in none of the sera of AIDS and ARC patients; enhancing activity could be detected in four and 12 sera, respectively. A significant positive correlation was observed between the titres of neutralizing antibodies measured in the complement-restored samples and the absolute number of CD4+ lymphocytes. These findings indicate that the appearance of complement-dependent enhancing antibodies coincident with the loss of neutralizing antibodies may indicate a poor prognosis in HIV infection.

AB - Reclustering and indirect immunofluorescence assays on MT-4 cells [carrying both CD4 and complement receptor type 2 (CR2)] were used to measure neutralizing and enhancing antibodies in sera obtained from HIV-1-infected individuals. Heat-inactivated sera were tested before and after mixing 1:1 with fresh seronegative human serum. Using heated samples, neutralizing antibodies were found in 20 out of 20 and 11 out of 19 serum samples of asymptomatic and symptomatic [AIDS, AIDS-related complex (ARC)] HIV-seropositive patients, respectively. In complement-restored samples, neutralizing activity was found in eight sera of asymptomatic patients and in none of the sera of AIDS and ARC patients; enhancing activity could be detected in four and 12 sera, respectively. A significant positive correlation was observed between the titres of neutralizing antibodies measured in the complement-restored samples and the absolute number of CD4+ lymphocytes. These findings indicate that the appearance of complement-dependent enhancing antibodies coincident with the loss of neutralizing antibodies may indicate a poor prognosis in HIV infection.

KW - AIDS

KW - ARC

KW - Complement receptors

KW - MT-4

KW - Neutralizing and enhancing HIV antibodies

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=0025796729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025796729&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 263

EP - 268

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 3

ER -